Le Lézard
Classified in: Health, Science and technology
Subject: MRR

Dermatology Devices Market Size to Reach USD 16.13 Billion in 2030 | Emergen Research

VANCOUVER, BC, Feb. 1, 2023 /PRNewswire/ -- The dermatology devices market size reached USD 5.46 Billion in 2021 and is expected to register a CAGR of 12.7% during the forecast period, according to latest analysis by Emergen Research. One key factor driving market revenue growth is rising prevalence of skin disorders. Public health is seriously affected by skin problems. Approximately between 70% and 30% of individuals across the world are affected. Chronic and acute skin problems affecting individuals of every age and socioeconomic backgrounds total more than 3000 in number. In terms of years lost owing to disability, skin conditions came in as the fourth most common non-fatal burden. In the upcoming years, there will thus be a greater need for diagnostics as well as treatment technologies for the treatment of various skin conditions.

Emergen Research Logo

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @


Demand for dermatology devices has significantly increased over the years owing to hi-tech innovations in aesthetic procedures and increasing FDA approvals for such new technologies. For instance, on 19 October 2022, The U.S. Food and Drug Administration (FDA) approved the use of Vivace Ultra, the next generation as well as the future of individualized aesthetics. The device is intended for hemostasis and electrocoagulation operations in general surgical procedures and dermatologic. Furthermore, analysis of pictures of symptoms suggestive and prompt creation of a comprehensive, microscopic image of the skin demonstrates the potential of a new virtual histology technique. It accomplishes this by eliminating a number of commonly utilized processes in diagnosis, such as tissue fixation, skin biopsy, processing, sectioning, and histochemical staining.


There are numerous issues and difficulties facing the dermatology devices industry. Stringent regulatory policies for Medical Devices (MD) are one such factor. For instance, market revenue growth will be impacted by the new Medical Device Regulation (MDR) (Regulation EU 2017/745), which will have a substantial impact on suppliers of MD. The reclassification of medical device applications and software results in tighter regulatory authority supervision plus documentation standards, such as clinical evidence. To the advantage of the patients, the adjustments are expected to improve quality.

Growth Projections:

The dermatology devices market is expected to register a CAGR of 12.7% over the forecast period and revenue is projected to increase from USD 5.46 Billion in 2021 to USD 16.13 Billion in 2030. Devices that can be utilized at home to address dermatologic problems and cosmetic issues are becoming ever more popular. Lasers, intense pulsed light, radiofrequency, ultraviolet B phototherapy, and light-emitting diodes are examples of commercially accessible equipment. Home-based treatments are becoming increasingly popular since they are practical and affordable. Numerous FDA-approved dermatological home care products, a majority of which involve light, are already available on the market as a consequence of high consumer demand. This shift to care provided at home could be accelerated even more by the recent development of teledermatology.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1462

Current Trends and Innovations:

The dermatology devices industry is undergoing gradual change as a result of new technology and innovations. Dermatologists will soon be able to detect as well as treat skin conditions more accurately and successfully owing to digital technology. The use of lasers to enhance skin texture is one of the important developments currently.  It could be accomplished using a variety of laser procedures, including laser hair removal, laser resurfacing, and laser vein therapy. Virtual Reality (VR), Artificial intelligence (AI), and other aesthetic procedures are being used in cosmetic dermatology as technology gets better. VR can be employed to mimic the effects of therapies, AI has the potential to diagnose skin issues and suggest remedies, and cosmetic procedures can be utilized to enhance the appearance of skin.

Strategic Initiatives:

Major companies included in the market report are Alma Lasers, Cutera, Cynosure, Lumenis Be Ltd., Bausch Health Companies Inc., Bruker, ZEISS International, Genesis Biosystems, Inc., HEINE Optotechnik GmbH & Co. KG, Michelson Diagnostics Limited.

Browse Full Report Description + Research Methodology + Table of Content + [email protected] https://www.emergenresearch.com/industry-report/dermatology-devices-market

Scope of Research

Report Details


Market size in 2021

USD 5.46 Billion

CAGR (2022?2030)

12.7 %

Revenue forecast to 2030

USD 16.13 Billion

Base year for estimation


Historical data


Forecast period


Quantitative units

Revenue in USD Million and CAGR in % from 2022 to 2030.

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends.

Segments covered

Product, application, end-use, region.

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa.

Country scope

U.S., Canada, Mexico, Germany, U.K., France, Spain, BENELUX, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, Israel, Rest of MEA.

Key companies profiled

Alma Lasers, Cutera, Cynosure, Lumenis Be Ltd., Bausch Health Companies Inc., Bruker, ZEISS International, Genesis Biosystems, Inc., HEINE Optotechnik GmbH & Co. KG, Michelson Diagnostics Limited

Customization scope

10 hours of free customization and expert consultation.

Custom Requirements can be requested for this Report [Customization Available] @

Emergen Research has segmented dermatology devices market on the basis of product, application, end-use, and region:

Latest Research Reports Published by Emergen Research:

Wearable Tattoo Monitors Market, By Application (Sports & Fitness, Remote Patient Monitoring), By Type (Graphene Tattoo, Nano Tattoo), By Product (Smart Tattoo), By Region Forecast to 2032

Medical Grade Hyaluronic Acid Market, By Industry (Pharmaceutical, Nutraceutical, and Others), By Application (Cosmetics, Dermal Fillers, Osteoarthritis, and Others), and By Region Forecast to 2032

Sensory Organ Drugs Market, By Organ Type (Eyes, Ears, Nose, and Others), By Route of Administration (Oral Route, Nasal Route, and Others), By End-Use (Hospitals, Home-Care Settings, and Others), and By Region Forecast to 2032

Chronic Graft versus Host Disease Market, By Treatment Type (Corticosteroids, Tyrosine Kinase Inhibitors, Monoclonal Antibodies, Others), By Distribution Channel, By Region Forecast to 2030

Digital Pathology Market, By Product (Hardware, Software), By Application (Primary Disease Diagnosis, Drug Discovery), By End-use (Biotechnology Industry, Hospitals), By Region Forecast to 2030

Cable Trunking Market By Type (Surface-Mounted Trunking, Floor Trunking, Ladder Trunking, Others), By Material (Polyvinyl Chloride [PVC], Stainless Steel, Aluminum, Others), By Application, and By Region Forecast to 2032

Tachograph Cards Market By Type (Analogue, Digital, and Smart), By Usage (Drivers Cards, Company Cards, Workshop Cards, and Company Cards), By Application (Passenger Vehicles and Commercial Vehicles), and By Region Forecast to 2032

Battery Tester Market, By Product (Carbon Pile Battery Tester and Others), By End-Use (Energy & Power and Others) and By Region Forecast to 2032

Noninvasive Hemoglobin Monitoring Devices Market, By Product Type (Continuous Hemoglobin Monitor and Spot Check Hemoglobin Monitor), By Application (Anemia, Polycythemia, and Others), By End-Use, and By Region Forecast to 2032

Fetal Monitoring Market, By Product (Ultrasound Devices, Electronic Maternal/Fetal Monitors, Fetal Doppler Devices, and Uterine Contraction Monitors), By Portability, By Method, By Application, By End-Use, and By Region Forecast to 2032

About Emergen Research 

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read our Press Release @ https://www.emergenresearch.com/press-release/global-dermatology-devices-market
Trending Titles LiDAR Market | Metaverse Market

Logo: https://mma.prnewswire.com/media/1579538/Emergen_Research_Logo.jpg 

These press releases may also interest you

at 03:05
PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, and Royalty Pharma , the largest buyer of biopharmaceutical royalties and a leading...

at 03:00
Allied Market Research published a report, titled, "Probiotic Desserts Market By Type (Dairy Based, Plant Based), By Application (Yogurt, Kefir, Ice Cream, Others), By Distribution Channel (Ecommerce, Specialty Store, Hypermarket and Supermarket,...

at 02:35
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including non-alcoholic...

at 02:35
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and...

at 02:17
111, Inc. ("111" or the "Company") , a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the fourth quarter...

at 02:05
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today reported its consolidated financial results1 for the year ending December 31, 2022. The consolidated financial statements are attached to this press release. "In...

News published on 1 february 2023 at 13:00 and distributed by: